WWTR1 and hemangioendothelioma: However, given the high predominance of WWTR1‐CAMTA1 gene fusions in patients with hemangioendothelioma and the consistency in demographics and survival outcomes that we demonstrated between the separate EHE and malignant hemangioendothelioma groups, we believe that this data still reflects a useful comparator.